IE
IMNM icon

Israel Englander’s Immunome IMNM Stock Holding History

Israel Englander’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-130,367
Closed -$2.85M – 6107
2026
Q1 		$2.85M Buy
130,367
+111,571
+594% +$2.48M ﹤0.01% 3517
2025
Q4 		$404K Sell
18,796
-23,088
-55% -$405K ﹤0.01% 5079
2025
Q3 		$490K Sell
41,884
-71,668
-63% -$713K ﹤0.01% 5084
2025
Q2 		$1.06M Sell
113,552
-347,507
-75% -$2.85M ﹤0.01% 4363
2025
Q1 		$3.1M Buy
461,059
+302,631
+191% +$2.9M ﹤0.01% 3348
2024
Q4 		$1.68M Buy
+158,428
New +$1.91M ﹤0.01% 3780
2024
Q2 		– Sell
-465,286
Closed -$11.5M – 6198
2024
Q1 		$11.5M Buy
465,286
+429,268
+1,192% +$8.71M ﹤0.01% 2055
2023
Q4 		$385K Buy
36,018
+6,927
+24% +$57.6K ﹤0.01% 4809
2023
Q3 		$243K Sell
29,091
-36,915
-56% -$271K ﹤0.01% 5025
2023
Q2 		$522K Sell
66,006
-83,644
-56% -$457K ﹤0.01% 4507
2023
Q1 		$747K Buy
+149,650
New +$732K ﹤0.01% 4333
2021
Q4 		– Sell
-21,089
Closed -$514K – 7074
2021
Q3 		$514K Sell
21,089
-15,581
-42% -$272K ﹤0.01% 5324
2021
Q2 		$634K Buy
+36,670
New +$810K ﹤0.01% 5095
2021
Q1 		– Sell
-67,863
Closed -$657K – 6199
2020
Q4 		$657K Buy
+67,863
New +$792K ﹤0.01% 4006

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Israel Englander's IMNM Position: Q2 2026 in Review

Israel Englander sold out of Immunome (IMNM) in Q2 2026, closing a stake of 130,367 shares — an estimated $2.85M sold.

Israel Englander first reported a position in IMNM in Q4 2020 and held it in 14 quarters. The position peaked at $11.5M in Q1 2024. 200 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Israel Englander reported no remaining Immunome position as of Q2 2026 after selling out during the quarter.
  • Israel Englander sold 130,367 Immunome shares in Q2 2026, an estimated $2.85M.
  • Israel Englander first reported a position in Immunome in Q4 2020 and held it in 14 quarters.
  • Israel Englander's Immunome position peaked at $11.5M in Q1 2024.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.